Literature DB >> 18187666

In human macrophages the complement component C5a induces the expression of oncostatin M via AP-1 activation.

Stefan P Kastl1, Walter S Speidl, Christoph Kaun, Katharina M Katsaros, Gersina Rega, Taras Afonyushkin, Valery N Bochkov, Peter Valent, Afshin Assadian, Georg W Hagmueller, Martina Hoeth, Rainer de Martin, Yongsheng Ma, Gerald Maurer, Kurt Huber, Johann Wojta.   

Abstract

OBJECTIVE: Macrophages produce the cytokine oncostatin M (OSM), which beside other functions is also involved in inflammation. The complement component C5a mobilizes and activates these cells at inflammatory sites. We examined the effect of C5a on OSM production in human monocytes and in human monocyte-derived macrophages. METHODS AND
RESULTS: For macrophage transformation peripheral blood monocytes were cultivated for 8 to 10 days in the presence of human serum. C5a significantly increased in these cells OSM antigen as determined by specific ELISA and mRNA as quantitated by real-time polymerase chain reaction in these cells as well as in plaque macrophages. This effect was blocked by antibodies against the receptor C5aR/CD88 and by pertussis toxin. The C5a-induced phosphorylation of p38 and JNK and the C5a-induced increase in OSM production in macrophages was abolished by 2 p38 inhibitors and by a JNK inhibitor. Furthermore C5a increased the nuclear translocation of c-fos and c-jun. Using different OSM promoter deletion mutant constructs we show that the putative AP-1 element is responsible for activation of OSM promoter activity by C5a.
CONCLUSIONS: Our data establish a link between the complement system and the gp130 receptor cytokine family with possible implications for the pathology of inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18187666     DOI: 10.1161/ATVBAHA.107.160580

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  16 in total

1.  Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes.

Authors:  Peter Popp Wibroe; Aaron C Anselmo; Per H Nilsson; Apoorva Sarode; Vivek Gupta; Rudolf Urbanics; Janos Szebeni; Alan Christy Hunter; Samir Mitragotri; Tom Eirik Mollnes; Seyed Moein Moghimi
Journal:  Nat Nanotechnol       Date:  2017-04-10       Impact factor: 39.213

Review 2.  The barrier hypothesis and Oncostatin M: Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease.

Authors:  Kathryn L Pothoven; Robert P Schleimer
Journal:  Tissue Barriers       Date:  2017-06-13

3.  Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis.

Authors:  Griet A Van Roey; Christopher C Vanison; Jeffanie Wu; Julia H Huang; Lydia A Suh; Roderick G Carter; James E Norton; Stephanie Shintani-Smith; David B Conley; Kevin C Welch; Anju T Peters; Leslie C Grammer; Kathleen E Harris; Kathryn E Hulse; Atsushi Kato; Whitney W Stevens; Robert C Kern; Robert P Schleimer; Bruce K Tan
Journal:  J Allergy Clin Immunol       Date:  2016-12-12       Impact factor: 10.793

Review 4.  Mesenchymal stem cell-macrophage crosstalk and bone healing.

Authors:  Jukka Pajarinen; Tzuhua Lin; Emmanuel Gibon; Yusuke Kohno; Masahiro Maruyama; Karthik Nathan; Laura Lu; Zhenyu Yao; Stuart B Goodman
Journal:  Biomaterials       Date:  2018-01-02       Impact factor: 12.479

5.  IL-27 inhibits OSM-mediated TNF-alpha and iNOS gene expression in microglia.

Authors:  Brandi J Baker; Keun W Park; Hongwei Qin; Xiangyu Ma; Etty N Benveniste
Journal:  Glia       Date:  2010-07       Impact factor: 7.452

6.  Neutrophils are a major source of the epithelial barrier disrupting cytokine oncostatin M in patients with mucosal airways disease.

Authors:  Kathryn L Pothoven; James E Norton; Lydia A Suh; Roderick G Carter; Kathleen E Harris; Assel Biyasheva; Kevin Welch; Stephanie Shintani-Smith; David B Conley; Mark C Liu; Atsushi Kato; Pedro C Avila; Qutayba Hamid; Leslie C Grammer; Anju T Peters; Robert C Kern; Bruce K Tan; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2016-12-18       Impact factor: 10.793

7.  Prostaglandin E₂ induces oncostatin M expression in human chronic wound macrophages through Axl receptor tyrosine kinase pathway.

Authors:  Kasturi Ganesh; Amitava Das; Ryan Dickerson; Savita Khanna; Narasimham L Parinandi; Gayle M Gordillo; Chandan K Sen; Sashwati Roy
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

8.  IgA Nephropathy Susceptibility Loci and Disease Progression.

Authors:  Manman Shi; Yan Ouyang; Mingxin Yang; Meng Yang; Xiaoyan Zhang; Wei Huang; Weiming Wang; Zhaohui Wang; Wen Zhang; Xiaonong Chen; Xiaoxia Pan; Hong Ren; Nan Chen; Jingyuan Xie
Journal:  Clin J Am Soc Nephrol       Date:  2018-07-24       Impact factor: 8.237

9.  Gp130-dependent release of acute phase proteins is linked to the activation of innate immune signaling pathways.

Authors:  Maren Luchtefeld; Christoph Preuss; Frank Rühle; Eskindir P Bogalle; Anika Sietmann; Stefanie Figura; Werner Müller; Karsten Grote; Bernhard Schieffer; Monika Stoll
Journal:  PLoS One       Date:  2011-05-04       Impact factor: 3.240

10.  Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis.

Authors:  Krzysztof Kiryluk; Yifu Li; Simone Sanna-Cherchi; Mersedeh Rohanizadegan; Hitoshi Suzuki; Frank Eitner; Holly J Snyder; Murim Choi; Ping Hou; Francesco Scolari; Claudia Izzi; Maddalena Gigante; Loreto Gesualdo; Silvana Savoldi; Antonio Amoroso; Daniele Cusi; Pasquale Zamboli; Bruce A Julian; Jan Novak; Robert J Wyatt; Krzysztof Mucha; Markus Perola; Kati Kristiansson; Alexander Viktorin; Patrik K Magnusson; Gudmar Thorleifsson; Unnur Thorsteinsdottir; Kari Stefansson; Anne Boland; Marie Metzger; Lise Thibaudin; Christoph Wanner; Kitty J Jager; Shin Goto; Dita Maixnerova; Hussein H Karnib; Judit Nagy; Ulf Panzer; Jingyuan Xie; Nan Chen; Vladimir Tesar; Ichiei Narita; Francois Berthoux; Jürgen Floege; Benedicte Stengel; Hong Zhang; Richard P Lifton; Ali G Gharavi
Journal:  PLoS Genet       Date:  2012-06-21       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.